Ingredion Incorporated (INGR)
| Previous close | 114.33 |
| Open | 113.78 |
| Bid | 115.12 x 900 |
| Ask | 115.29 x 1000 |
| Day's range | 113.98 - 115.22 |
| 52-week range | 89.54 - 118.83 |
| Volume | |
| Avg. volume | 414,090 |
| Market cap | 7.559B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 12.00 |
| EPS (TTM) | 9.60 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | 3.12 (2.73%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 127.83 |
Simply Wall St.Ingredion Incorporated's (NYSE:INGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Ingredion (NYSE:INGR) has had a rough month with its share price down 4.1%. However, a closer look at its sound...
GlobeNewswireIngredion to Release 2024 First Quarter Financial Results on May 8, 2024
WESTCHESTER, Ill., April 17, 2024 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its 2024 first quarter financial results for the period ended March 31, 2024, before the market opens Wednesday, May 8, 2024. Jim Zallie, president and chief executive officer and Jim Gray, executive vice president and chief financial officer, will host a conference call May 8 at 8 a.m. CT to discuss the Comp
- GlobeNewswire
Dr. Michael Leonard Joins Ingredion as Senior Vice President, Chief Innovation Officer and Head of Protein Fortification
WESTCHESTER, Ill., April 15, 2024 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced the appointment of Dr. Michael Leonard to the role of senior vice president, chief innovation officer and head of protein fortification, effective May 13, 2024. Leonard will serve as a member of the Company’s executive leadership team and will report to Jim Zallie, president and chief executive officer. Ove
